DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Vasey PA, Shulman LN, Campos S et al.
Phase I trial of intraperitoneal injection of the E1B-55-kd-gene-deleted adenovirus ONYX-015 (dl1520) given on days 1 through 5 every 3 weeks in patients with recurrent/refractory epithelial ovarian cancer.
J Clin Oncol 2002;
20: 1562-1569
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.